Paul Herzich

CIK: 0001954991

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (33.3%)

Position reduction

Option Exercises (M)6 (33.3%)

Derivative conversions

Awards (A)6 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SLDB

Solid Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

SLDB
Solid Biosciences Inc.
Feb 18, 2026
Sale(S)
Direct
3.6K shares at avg. $5.82$21K
SLDB
Solid Biosciences Inc.
Feb 13, 2026
Exercise(M)
Direct
7.2K shares-
SLDB
Solid Biosciences Inc.
Feb 4, 2026
Sale(S)
Direct
10.9K shares at avg. $6.44$70K
SLDB
Solid Biosciences Inc.
Feb 2, 2026
Sale(S)
Direct
26.3K shares at avg. $6.44$169K
SLDB
Solid Biosciences Inc.
Jan 31, 2026
Exercise(M)
Direct
24.7K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
54.9K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
170K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Exercise(M)
Direct
54.9K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
85K shares-
SLDB
Solid Biosciences Inc.
Dec 3, 2025
Sale(S)
Direct
2.7K shares at avg. $5.11$14K
SLDB
Solid Biosciences Inc.
Dec 2, 2025
Exercise(M)
Direct
7.2K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
100K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Restricted Stock Units
Direct
50K shares-
SLDB
Solid Biosciences Inc.
Feb 14, 2025
Sale(S)
Direct
2.7K shares at avg. $3.96$11K
SLDB
Solid Biosciences Inc.
Feb 13, 2025
Exercise(M)
Direct
7.2K shares-
SLDB
Solid Biosciences Inc.
Jan 31, 2025
Award(A)
Restricted Stock Units
Direct
98.7K shares-
SLDB
Solid Biosciences Inc.
Dec 3, 2024
Sale(S)
Direct
2.8K shares at avg. $5.60$16K
SLDB
Solid Biosciences Inc.
Dec 2, 2024
Exercise(M)
Direct
7.2K shares-

		Type	Shares	Price		Ownership
Feb 18, 2026	SLDB Solid Biosciences Inc.	Sale(S)	3,616	$5.82	$21,057	Direct
Feb 13, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	7,187	-	$0	Direct
Feb 4, 2026	SLDB Solid Biosciences Inc.	Sale(S)	10,905	$6.44	$70,249	Direct
Feb 2, 2026	SLDB Solid Biosciences Inc.	Sale(S)	26,250	$6.44	$168,969	Direct
Jan 31, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	24,675	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	54,925	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	170,000	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	54,925	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	85,000	-	-	Direct
Dec 3, 2025	SLDB Solid Biosciences Inc.	Sale(S)	2,701	$5.11	$13,802	Direct
Dec 2, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	7,239	-	-	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	100,000	-	-	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	50,000	-	-	Direct
Feb 14, 2025	SLDB Solid Biosciences Inc.	Sale(S)	2,688	$3.96	$10,644	Direct
Feb 13, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	7,187	-	-	Direct
Jan 31, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	98,700	-	-	Direct
Dec 3, 2024	SLDB Solid Biosciences Inc.	Sale(S)	2,777	$5.60	$15,551	Direct
Dec 2, 2024	SLDB Solid Biosciences Inc.	Exercise(M)	7,239	-	$0	Direct

1-18 of 18 transactions

About Herzich Paul

Herzich Paul (SEC CIK 0001954991) files insider reports with the SEC as Chief Technology Officer of Solid Biosciences Inc. (SLDB).

Signal8 holds 9 ownership filings by Herzich Paul, all Form 4s, filed between Dec 4, 2024 and Apr 21, 2026. Those filings report 18 transactions, from Dec 2, 2024 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Herzich Paul's filings is in CHARLESTOWN, MA.

Recent filings by Herzich Paul

Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 2, 2026: Open-market sale of SLDB shares (Form 4, code S).
Jan 31, 2026: Option exercise of SLDB shares (Form 4, code M).

Other insiders filing for Solid Biosciences Inc. (SLDB)

Ganot Ilan, Director
Brooks Gabriel, Chief Medical Officer
SMITH IAN F, Director
RA CAPITAL MANAGEMENT, L.P., 10% Owner
Nagendran Sukumar, Director
PERCEPTIVE ADVISORS LLC, Director

How to read Form 4 transaction codes